Jim Cramer Says He Was Wrong for Selling Johnson & Johnson for the Charitable Trust

Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s game plan for this week. Cramer explained why he sold the stock for the Charitable Trust, as he commented: "Wednesday morning brings two stocks that are hard to keep down. Johnson & Johnson and Charles Schwab. J&J has become a pure play on pharma by spinning off its orthopedics division. That’s smart because orthopedics happens to be a commoditized business. Meanwhile, its pharma business has some of the best drugs in the pipe, and they rea ...